Substance Abuse
Award date
January 2022
Amount
$97,500
Organization
Whylome
Purpose
To advance addiction treatment through innovative, research-backed approaches that combine medical and behavioral therapies.
Leveraging the latest research in neuroscience, pharmacology, and technology, Whylome focuses on developing and applying novel therapeutic solutions aimed at improving outcomes for individuals struggling with addiction and related mental health challenges. The company emphasizes a holistic, patient-centered approach that integrates both medical and behavioral therapies to create more effective treatment options.
In addition to its core work in addiction treatment, Whylome is committed to supporting the broader community through partnerships with healthcare providers, policymakers, and non-profit organizations. The company is actively involved in research initiatives and collaborates with academic institutions to explore new methodologies for addressing substance use disorders and co-occurring mental health issues. By combining cutting-edge science with a strong social mission, Whylome seeks to contribute to the ongoing evolution of addiction care and mental health services.